Smith & Nephew
Smith & Nephew plc is a British medical technology company that develops, manufactures, and markets advanced medical devices and surgical equipment worldwide. The company structures its operational business across three main global franchises, comprising Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Its product line includes joint replacement implants for hips and knees, arthroscopic surgery instruments, robotic-assisted surgical platforms, advanced bandage dressings, and biological wound-healing products. Revenue is principally generated from direct sales of medical devices, surgical implants, and single-use consumables to healthcare providers and hospital systems. Key end markets include orthopedic surgeons, trauma centers, outpatient surgical clinics, and acute care hospitals across North America, Europe, and Asia-Pacific. Holding leading global market positions in sports medicine joint repair and advanced wound treatment, the enterprise maintains an extensive international commercial footprint. Headquartered in Watford, United Kingdom, Smith & Nephew plc is publicly listed on the London Stock Exchange and the New York Stock Exchange.
60 of the funds FundTelligence covers report a position in Smith & Nephew.
- Legal name
- SMITH & NEPHEW PLC
- Sector
- Health Care
- Country
- United Kingdom
- Funds holding it
- 60
- Exposure themes
- Ageing & Longevity, Healthy Ageing & Function, Mobility & Orthopaedics
Funds holding Smith & Nephew
- Fondsfinans Global Helse — Fondsfinans · 2.01 % (full portfolio disclosed, October 2026)
- Nordea Globale Stabile Aktier - Etisk tilvalg — Nordea Funds · 1.48 % (full portfolio disclosed, July 2026)
- Nordea Global Stable Equity Fund - Unhedged — Nordea Funds · 1.18 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aktier — Nordea Funds · 1.17 % (full portfolio disclosed, July 2026)
- Nordea Global Stable Equity Fund — Nordea Funds · 1.16 % (full portfolio disclosed, July 2026)
- Nordea Globale Stabile Aktier — Nordea Funds · 1.16 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aksjer Global — Nordea Funds · 1.16 % (full portfolio disclosed, July 2026)
- Sparinvest European Value — Sparinvest · 1.04 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 60 funds holding it.